Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5673)
Korro Bio, Inc. (KRRO)
Aiyar Ram — Director
Shares
5,802
Price
$10.84
Total Value
$62.92K
Shares Held After
69,046
% of Holdings
7.8%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
800,000
Price
$0.50
Total Value
$400.00K
Shares Held After
883,886
% of Holdings
90.5%
MERIT MEDICAL SYSTEMS INC (MMSI)
Peterson Neil W. — CHIEF OPERATING OFFICER
Shares
21,449
Price
$85.00
Total Value
$1.82M
Shares Held After
25,551
% of Holdings
45.6%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
2,611
Price
$24.64
Total Value
$64.34K
Shares Held After
117,227
% of Holdings
2.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
1,500
Price
$23.87
Total Value
$35.80K
Shares Held After
119,838
% of Holdings
1.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,967
Price
$24.65
Total Value
$73.13K
Shares Held After
40,166
% of Holdings
6.9%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
1,794
Price
$23.89
Total Value
$42.86K
Shares Held After
43,133
% of Holdings
4.0%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
653
Price
$2.94
Total Value
$1.92K
Shares Held After
268,371
% of Holdings
0.2%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
653
Price
$2.95
Total Value
$1.92K
Shares Held After
328,737
% of Holdings
0.2%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
3,023
Price
$2.95
Total Value
$8.91K
Shares Held After
1,260,890
% of Holdings
0.2%
Jushi Holdings Inc. (JUSH)
Barack Louis Jon — President
Shares
10,000
Price
$0.43
Total Value
$4.30K
Shares Held After
2,883,773
% of Holdings
0.3%
Tilray Brands, Inc. (TLRY)
Merton Carl A — Chief Financial Officer
Shares
10,000
Price
$4.62
Total Value
$46.20K
Shares Held After
139,753
% of Holdings
7.2%
Hepion Pharmaceuticals, Inc. (HEPA)
Appajosyula Sireesh — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
16,250,000
% of Holdings
12.3%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
8,000,000
Price
$0.05
Total Value
$400.00K
Shares Held After
14,250,000
% of Holdings
56.1%
Hepion Pharmaceuticals, Inc. (HEPA)
Purcell Michael J. — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. II — Director
Shares
500,000
Price
$0.05
Total Value
$25.00K
Shares Held After
500,000
% of Holdings
100.0%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
BIOGEN INC. (BIIB)
Minor Lloyd — Director
Shares
593
Price
$203.34
Total Value
$120.58K
Shares Held After
3,282
% of Holdings
15.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
4,375
Price
$26.12
Total Value
$114.26K
Shares Held After
717,203
% of Holdings
0.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
955
Price
$26.12
Total Value
$24.94K
Shares Held After
119,289
% of Holdings
0.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
1,230
Price
$26.12
Total Value
$32.12K
Shares Held After
126,171
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
100
Price
$97.10
Total Value
$9.71K
Shares Held After
97,994
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,300
Price
$96.30
Total Value
$221.49K
Shares Held After
98,094
% of Holdings
2.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,100
Price
$95.21
Total Value
$485.57K
Shares Held After
100,394
% of Holdings
4.8%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
16
Price
$97.46
Total Value
$1.56K
Shares Held After
567,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
1,392
Price
$96.82
Total Value
$134.77K
Shares Held After
567,556
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,635
Price
$95.93
Total Value
$540.57K
Shares Held After
568,948
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
7,157
Price
$95.10
Total Value
$680.63K
Shares Held After
574,583
% of Holdings
1.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
800
Price
$93.97
Total Value
$75.18K
Shares Held After
581,740
% of Holdings
0.1%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
334
Price
$267.99
Total Value
$89.51K
Shares Held After
170,073
% of Holdings
0.2%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
317
Price
$267.99
Total Value
$84.95K
Shares Held After
52,115
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
109
Price
$267.99
Total Value
$29.21K
Shares Held After
245,614
% of Holdings
0.0%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
731
Price
$267.99
Total Value
$195.90K
Shares Held After
2,275,394
% of Holdings
0.0%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
128
Price
$268.70
Total Value
$34.39K
Shares Held After
129,019
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,233
Price
$267.79
Total Value
$330.18K
Shares Held After
129,147
% of Holdings
0.9%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
192
Price
$265.27
Total Value
$50.93K
Shares Held After
130,380
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
947
Price
$263.94
Total Value
$249.95K
Shares Held After
130,572
% of Holdings
0.7%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
200
Price
$261.49
Total Value
$52.30K
Shares Held After
131,519
% of Holdings
0.2%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
300
Price
$259.98
Total Value
$77.99K
Shares Held After
131,719
% of Holdings
0.2%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
410
Price
$267.99
Total Value
$109.88K
Shares Held After
132,019
% of Holdings
0.3%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
612
Price
$268.22
Total Value
$164.15K
Shares Held After
99,897
% of Holdings
0.6%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
296
Price
$267.08
Total Value
$79.06K
Shares Held After
100,509
% of Holdings
0.3%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
80
Price
$265.27
Total Value
$21.22K
Shares Held After
100,805
% of Holdings
0.1%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
676
Price
$263.86
Total Value
$178.37K
Shares Held After
100,885
% of Holdings
0.7%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
70
Price
$261.02
Total Value
$18.27K
Shares Held After
101,561
% of Holdings
0.1%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
160
Price
$259.98
Total Value
$41.60K
Shares Held After
101,631
% of Holdings
0.2%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
295
Price
$267.99
Total Value
$79.06K
Shares Held After
183,774
% of Holdings
0.2%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
1,182
Price
$267.99
Total Value
$316.76K
Shares Held After
101,791
% of Holdings
1.1%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
6,250
Price
$137.37
Total Value
$858.56K
Shares Held After
162,500
% of Holdings
3.7%
Showing 251–300 of 5673 transactions (page 6 of 114)